The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies.
Related Posts
Changing use and perceptions – Healthcare Economist
Conventional wisdom holds that alcohol use is part of American culture…but perhaps this is changing. According to a Gallup poll […]
U.S. Foreign Aid Freeze & Dissolution of USAID: Timeline of Events
Starting on his first day of his second term in office, President Trump and his administration have taken several executive actions that directly impact U.S. […]
How to Get AI to Recommend and Cite Your Healthcare Brand
How do healthcare organizations stay visible and trusted as search shifts from clicks to AI-generated answers? In this week’s podcast, Stewart Gandolf sits down with […]